|Make USBio your source of antibiotics.
In addition to having low prices on such commonly used antibiotics as Tetracycline, Ampicillin, and Kanamycin, United States Biological provides a wide range of more novel antibiotics. Recent research has recognized fumitremorgin C as a potent and specific inhibitor of the breast cancer resistance protein (BCRP/ABCG2) multidrug transporter. Concanamycin A inhibits the acidification of organelles and blocks cell surface expression of viral envelope glycoproteins without affecting their synthesis. Oligomycin B makes cells more susceptible to cell death and also leads to a switch in the death mode from apoptosis to necrosis.
Other Notable Antibiotics
A2297-39 Antibiotic UCN-01
(7-Hydroxystaurosporine, UCN-01): Antibiotic UCN-01 is a indolocarbazole isolated from a high staurosporine-producing Streptomyces culture. UCN-01 inhibits protein kinase C (PKC) and cyclin-dependant kinase 2 (CDK2) resulting in accumulation of cells in the G1 phase and induction of apoptosis.
TPU-0037A, a close structural analogue of lydicamycin, has been shown to be highly active against MRSA
Indolmycin (Antibiotic PA 155A)
Recent research has shown that indolmycin is active against Mycobacteria and Helicobacter pylori and can stimulate transcription in Escherichia coli.
The antitumor potential of fostriecin has attracted considerable interest, focused on its mode of action as a topoisomerase II inhibitor.
Piericidin A inhibits both mitochondrial and bacterial NADH-ubiquinone oxidoreductases, binding close to NUOD-NUOB interface.
Quiniomycin A has broad activity against bacteria, fungi and viruses and has found application as an antitumor agent.
Ristocetin A Sulphate
Ristocetin A induces platelet aggregation by binding to a factor absent in people suffering from von Willebrands disease.